IMARC Group, a leading market research company, has recently released a report titled "Bioresorbable Polymers Market Size, Share, Trends and Forecast by Product, Application, and Region, 2025-2033" The study provides a detailed analysis of the industry, including the global bioresorbable polymers market share, size, growth, trends, and forecast. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Bioresorbable Polymers Market Overview

The global bioresorbable polymers market was valued at USD 1.62 Billion in 2024 and is projected to reach USD 3.77 Billion by 2033, growing at a CAGR of 9.37% during the forecast period from 2025 to 2033. North America leads the market with over 33.5% share in 2024, driven by healthcare industry growth, chronic disease prevalence, and demand from orthopedic and drug delivery applications. Advanced polymer innovations and R&D activities further fuel the market expansion.

Study Assumption Years

• Base Year: 2024
• Historical Year/Period: 2019-2024
• Forecast Year/Period: 2025-2033

Bioresorbable Polymers Market Key Takeaways

• Current Market Size: USD 1.62 Billion in 2024
• CAGR: 9.37%
• Forecast Period: 2025-2033
• North America dominates the market with over 33.5% share in 2024.
• Orthopedics is the leading application with around 44.5% market share in 2024.
• Polylactic acid (PLA) leads the product segment with approximately 28.9% market share in 2024.
• Increasing prevalence of chronic diseases and demand for minimally invasive surgeries drive market growth.
• Rising research and development investments and regulatory support boost innovation and adoption.

Request Your Free “Bioresorbable Polymers Market” Insights Sample PDF: https://www.imarcgroup.com/bioresorbable-polymers-market/requestsample

Market Growth Factors

The bioresorbable polymers market is driven by the growing demand for advanced medical devices and its application in drug delivery systems, in tissue engineering and as a surgical implant, due to increase in prevalence of chronic diseases across the globe and the increase in adoption of minimally intrusive surgeries (MIS). For instance, Zeus Inc. launched Absorv™ XSE-oriented tubing to fill the gap of permanent metallic stents in September 2023, improving device design and performance while achieving better clinical outcomes.

The market is also driven by technological advances by being able to improve biocompatibility and biodegradability of polymers, and thereby extending their applications into orthopedics and cardiovascular devices. The use of bioresorbable metal implants has been approved by the FDA for Bioretec Ltd in March 2023. Increasing investments in the healthcare industry are also expected to propel the growth of the bioresorbable implants market.

Besides medical applications, the global trend towards more sustainable materials creates a market for bioresorbable polymers as an alternative to conventional plastics in packaging, automotive, and agriculture. An example is Solvay's Naternal family (introduced in June 2023), which for hair and skin care consists of biodegradable polymers, illustrating the expansion of applications and demand and regulatory pressure factors.

Market Segmentation

Breakup by Product:

• Polysaccharides: Naturally derived polymers valued for biodegradability and diverse biomedical applications.
• Proteins: Bio-based polymers used in tissue engineering and drug delivery due to biocompatibility.
• Polylactic Acid: Leading polymer with 28.9% market share in 2024, known for biocompatibility, biodegradability, and versatile healthcare applications.
• Polyglycolic Acid: Used in medical devices for controlled degradation and compatibility.
• Polycaprolactone: A biodegradable polymer used in long-term implants and drug delivery systems.
• Others: Includes various bioresorbable polymers used across medical and non-medical industries.

Breakup by Application:

• Drug Delivery: Utilizes polymers for controlled release and biodegradable delivery systems.
• Orthopedics: Dominant application with 44.5% market share in 2024, applied in bone fixation, implants, and surgical treatments reducing the need for removal surgeries.
• Others: Encompasses additional applications including cardiovascular devices and wound healing.

Breakup By Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America is the leading region for bioresorbable polymers, accounting for over 33.5% market share in 2024. The strong healthcare infrastructure, high demand for advanced medical technologies, and preference for minimally invasive surgeries contribute to this leadership. The U.S. specifically represents 82.50% of North American market revenue, supported by increasing chronic disease cases and significant healthcare expenditure of USD 4.3 trillion in 2021.

Recent Developments & News

• November 2024: Evonik revealed flame-retardant PA12 and carbon black-embedded 3D printing materials at Formnext 2024, enhancing their polymer portfolio.
• September 2024: Evonik Venture Capital and L’Oréal's BOLD fund participated in a €35 million round for Abolis Biotechnologies focused on sustainable biomanufacturing.
• August 2024: Ashland expanded its Ireland facility to boost bioresorbable polymer production, enabling injectable technologies and tissue engineering solutions.
• April 2024: Evonik increased RESOMER powder biomaterials capacity in Germany with new solvent-free micronization technology.
• March 2023: Evonik partnered with BellaSeno GmbH to utilize RESOMER polymers in innovative breast implants.
• August 2021: Evonik acquired JeNaCell, integrating innovative cellulose-based biomaterials into its healthcare portfolio.

Key Players

• Ashland Global Specialty Chemicals Inc.
• Bezwada Biomedical LLC
• Corbion N.V.
• Evonik Industries AG (RAG-Stiftung)
• Foster Corporation
• Nomisma Healthcare Pvt. Ltd.
• Poly-Med Incorporated
• Reva Medical LLC
• Seqens SAS
• Zeus Company Inc.

Ask Analyst For Request Customization: https://www.imarcgroup.com/request?type=report&id=7080&flag=E

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302